For medical-device manufacturers, software development is no longer just an engineering activity. Software increasingly determines device behavior, risk, update cycles, and the evidence manufacturers must preserve for regulators. IEC 62304 addresses this by defining a structured framework for medical-device software lifecycle processes. It affects how requirements, risks, reviews, changes, defects, releases, and maintenance are controlled.
The standard does not require one development methodology. Agile, iterative, DevOps, hybrid, and traditional models can all be compatible if required activities are planned, responsibilities are clear, outputs are controlled, and evidence remains traceable. The practical challenge is translating the standard into repeatable workflows across teams, suppliers, tools, and releases. A strong quality management system (QMS) provides that foundation.
Safety Classification Should Shape the Lifecycle From the Start
Software safety classification is an early planning decision because it affects the rigor expected throughout the lifecycle. IEC 62304 uses Classes A, B, and C according to the potential consequences of software failure and related hazardous situations. Classification should influence planning, architecture, documentation, verification, review expectations, and evidence requirements from the beginning.
A well-designed QMS should make classification visible wherever it affects decisions. Requirements, changes, verification records, anomalies, and risk controls may need different review levels depending on the safety context. Workflow rules can route higher-risk changes to additional reviewers and block releases when required verification is incomplete.
Resources from organizations working at the intersection of MedTech software and regulatory operations can help teams develop a shared understanding of IEC 62304. Enlil, a platform that applies agentic AI to MedTech regulatory and development workflows, has published a practical guidance on IEC 62304 software safety classifications, offering useful context on how classification decisions can influence lifecycle controls. Such guidance should complement, not replace, a manufacturer’s own risk analysis, procedures, and regulatory judgment. The more important step is translating the selected classification into concrete QMS workflows, approval requirements, documentation practices, verification activities, and traceability rules. That is where classification becomes an operational part of software lifecycle planning across the development organization.
The QMS Must Turn Requirements Into Executable Workflows
A common mistake is to repeat IEC 62304 language in procedures without defining how required activities will occur. A procedure may state that software requirements must be reviewed but fail to specify where the review happens, who participates, what constitutes approval, and how evidence is retained. QMS software should close that gap through controlled workflows with defined states, permissions, responsibilities, approvals, and records.
Manufacturers should map the lifecycle before configuring the platform: which records are created, which systems are authoritative, which relationships must be preserved, and which approvals are mandatory. A requirement may connect to a hazardous situation, architecture, implementation, and several verification results. If records live in different systems, the QMS needs a deliberate strategy for maintaining traceability.
Traceability, Change Control, and Problem Resolution
In regulated MedTech, requirements form part of an evidence chain linking user needs, safety controls, architecture, implementation, verification, validation, and release decisions. Traceability should be maintained continuously, not assembled shortly before an audit.
Structured records and disciplined identifiers help identify missing verification, obsolete requirements, or changes not fully reassessed. Traceability should focus on meaningful engineering and regulatory relationships rather than excessive links.
Lifecycle planning must continue after release. Defects, dependency updates, and cybersecurity issues can trigger changes. Effective change control begins with impact assessment: teams should determine whether a change affects requirements, risks, architecture, cybersecurity assumptions, verification, labeling, manufacturing, or regulatory documentation. Problem-resolution records should also connect defects, complaints, test anomalies, CAPAs, and resulting software changes when they concern the same issue.
Suppliers, Cybersecurity, and QMS Assurance
Modern medical-device software often depends on operating systems, open-source libraries, cloud services, commercial components, and contractors. Lifecycle planning must define how third-party software is identified, evaluated, maintained, and linked to supplier controls. Supplier oversight should be proportional to the safety and performance impact of the supplied component or service.
Cybersecurity increases the importance of this control. A newly disclosed vulnerability may require a manufacturer to identify affected products, assess exploitability and patient impact, determine remediation, and document the decision. Accurate configuration data is essential for knowing which product versions contain affected software.
The QMS platform itself also needs risk-based assurance. Manufacturers should define its intended use and focus testing on functions, configurations, interfaces, permissions, workflows, and failure modes that could affect regulated decisions or records. Vendor updates, configuration changes, integrations, and migrations should also be evaluated for potential impact.
Audit Readiness Should Be Built Into Daily Work
Audit readiness should result from normal operations, not reconstruction before an inspection. When requirements, tests, defects, releases, approvals, and risk assessments are captured consistently, teams can explain software decisions without relying on emails or memory.
A well-implemented QMS should allow reviewers to move from a release to changed requirements, risk reassessments, verification evidence, unresolved anomalies, and approvals while preserving revision history. Metrics can also reveal overdue reviews, verification gaps, aging changes, recurring defects, supplier issues, or incomplete trace relationships before they become larger problems.
Start With the Lifecycle, Not the Software Vendor
Selecting a QMS platform before defining the operating model can force a manufacturer into workflows that do not match its products, risks, or development practices. A better sequence is to define required records, relationships, controlled decisions, ownership, and authoritative systems first, then determine how the QMS and engineering tools should support that model.
The central lesson of IEC 62304 is that compliant software development is a lifecycle capability, not a documentation event. When workflows, records, traceability, responsibilities, risk controls, and assurance activities operate as one connected system, regulatory evidence becomes a natural result of disciplined execution. This approach improves release decisions, reduces late remediation, strengthens audit readiness, and makes software changes easier to assess as products and organizations scale.
